LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Nasopharyngeal Pneumococcal Density Associated with Invasive Lung Disease

By LabMedica International staff writers
Posted on 30 Oct 2019
Print article
Image: A three-dimensional (3D) computer-generated image of a group of Gram-positive, Streptococcus pneumoniae bacteria that cause invasive pneumococcal disease. The artistic recreation was based upon scanning electron microscopic (SEM) imagery (Photo courtesy of Dan Higgins/US Centers of Disease Control and Prevention).
Image: A three-dimensional (3D) computer-generated image of a group of Gram-positive, Streptococcus pneumoniae bacteria that cause invasive pneumococcal disease. The artistic recreation was based upon scanning electron microscopic (SEM) imagery (Photo courtesy of Dan Higgins/US Centers of Disease Control and Prevention).
Streptococcus pneumoniae (pneumococcus) is one of the most important bacterial causes of pneumonia among children and adults worldwide. Nasopharyngeal pneumococcal colonization is common in young children and represents a critical initial step in the progression to invasive disease.

Increases in the density of pneumococci in the nasopharynx have been associated with the onset of respiratory illness and might also play a role in transmission of bacteria to others. Respiratory viruses are frequently detected in the nasopharynx of young children during asymptomatic periods.

An international team of scientists working with the Vanderbilt University Medical Center (Nashville, TN, USA) enrolled children less than 3 years of age, residing in the Peruvian study area, who were prospectively assessed for acute respiratory illness (ARI) symptoms during weekly household visits. An ARI episode was defined as the presence of either cough or fever and the team considered a child to be asymptomatic if the child had rhinorrhea alone or no ARI symptoms.

The investigators collected nasopharyngeal swabs from each child monthly, whether or not ARI symptoms were present, and tested the swabs by bacterial culture for pneumococcal identification and quantitative polymerase chain reaction (qPCR) for pneumococcal density determinations. A subset of nasopharyngeal samples were collected during asymptomatic periods underwent real-time reverse transcription PCR (rRT-PCR) viral testing or influenza virus (types A, B, and C), respiratory syncytial virus (RSV), human metapneumovirus (MPV), rhinovirus (HRV), adenovirus (AdV), and parainfluenza virus (PIV) types 1–3.

The team reported that a total, 849 nasopharyngeal samples collected during asymptomatic periods from 480 children underwent both viral testing and pneumococcal density determinations. Pneumococcus was detected in 566/849 (67%) nasopharyngeal samples from asymptomatic children. At least one respiratory virus was detected in 357/849 (42%) samples from asymptomatic children, most commonly HRV (31%) and AdV (11%), whereas detections of influenza, MPV, PIV, and RSV in asymptomatic children were uncommon (<3%).

Total pneumococcal densities (encompassing all present serotypes) during asymptomatic periods were significantly higher when a respiratory virus was detected versus when no virus was detected. In adjusted analyses, increased pneumococcal density was significantly associated with the risk for a subsequent ARI, whereas asymptomatic viral detection alone was associated with lower risk for subsequent ARI.

The authors concluded that viral detections during asymptomatic periods are associated with increases in nasopharyngeal pneumococcal colonization density. Furthermore, they found that pneumococcal density, especially at high levels, is associated with subsequent development of ARI in young children in Peru. These findings suggest that interactions between viruses and pneumococci in the nasopharynx during asymptomatic periods might have a role in onset of subsequent ARI. The study was published on October 15, 2019, in the journal Emerging Infectious Diseases.

Related Links:
Vanderbilt University Medical Center

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Sekisui Diagnostics UK Ltd.